Literature DB >> 599900

The role of inflammatory cells in the pathogenesis of amyloidosis.

R Kisilevsky, M Axelrad, W Corbett, S Brunet, F Scott.   

Abstract

In the presence of amyloid enhancing factor, a variety of inflammatory stimuli, many of them nonantigenic, trigger amyloid deposition in 48 hours. There is a striking correlation between the extent of splenic amyloid deposition and the severity of inflammation at the injection site of the various irritants. Sublethal irradiation results in a parallel effect on the local inflammatory response and the accompanying extent of amyloid deposition produced in the spleen. Evidence that a product of local acute inflammatory responses is related to the deposition of amyloid is also presented. It is proposed that this product is a protease derived from the infiltrating polymorphonuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 599900

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

1.  Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; Z Ali-Khan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.

Authors:  Lorena Saelices; Kevin Chung; Ji H Lee; Whitaker Cohn; Julian P Whitelegge; Merrill D Benson; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-28       Impact factor: 11.205

Review 3.  Amyloid and the lower respiratory tract.

Authors:  P J Thompson; K M Citron
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

4.  The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase.

Authors:  S L Silverman; E S Cathcart; M Skinner; A S Cohen
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

5.  Biochemical nature and cellular origin of amyloid enhancing factor (AEF) as determined by anti-AEF antibody.

Authors:  K Alizadeh-Khiavi; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1988-10

6.  Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.

Authors:  Masatoshi Omoto; Tadaaki Yokota; Dan Cui; Yoshinobu Hoshii; Hiroo Kawano; Toshikazu Gondo; Tokuhiro Ishihara; Takashi Kanda
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

7.  The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis.

Authors:  M L Baltz; D Caspi; B E Glatthaar; U Moser; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

8.  Chronic alveolar hydatidosis and secondary amyloidosis: pathological aspects of the disease in four strains of mice.

Authors:  T O Alkarmi; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1984-08

9.  Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors.

Authors:  G V Abankwa; Z Ali-Khan
Journal:  Br J Exp Pathol       Date:  1988-02

10.  Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species.

Authors:  K P McAdam; N T Foss; C Garcia; R DeLellis; L Chedid; R J Rees; S M Wolff
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.